None listed
Conditions
Interventions
Procedure/Surgery : - Symmetrical lesions on both sides of the patient's scalp are selected and randomly assigned to the test group/control group, and triamcinolone acetonide 2.5~5mg/ml is injected by
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Alopecia areata patients with symmetrical lesions on both sides of the scalp and less than 1 year from onset ? Those who voluntarily decides to participate after the detailed explanation of study and agrees in writing to abide by the precautions ? Men and women over the age of 20 ? Those who can be followed up during the trial period
Exclusion criteria
Exclusion criteria: ? Those with obvious hair regrowth on the symmetrical alopecia lesion on both sides of the scalp ? Persons with ophiasis pattern observed ? Those with other immune diseases other than alopecia areata ? Those who are receiving immunomodulatory drug treatment (oral or topical) ? Those with other diseases of the scalp or hair ? Women who are pregnant or lactating ? Those with immunocompromisation, uncontrolled diabetes or high blood pressure, and a tendency to bleeding ? Those with psychiatric disease ? Those who are judged by the principal investigator to be ineligible for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the average pain score evaluated by NRS in each group on both sides of the scalp | — |
Secondary
| Measure | Time frame |
|---|---|
| In Group 1, comparison of the triamcinolone injection effect evaluated by reducing the lesion area and increasing the hair density and thickness on both sides of the scalp | — |
Countries
Korea, Republic of
Contacts
Public ContactJi Won Lee
Seoul National University Hospital
Outcome results
None listed